Anacor Pharmaceuticals (ANAC) Said Second Phase 3 Trial of Tavaborole was Statistically Significant
Tweet Send to a Friend
Anacor Pharmaceuticals (NASDAQ: ANAC) is trading up 3 percent after-hours after the company announced positive preliminary results from the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
